Cargando…

Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry

AIMS: Catheter-based renal artery denervation (RDN) has been shown to lower blood pressure (BP) in certain patients with uncontrolled hypertension. Isolated systolic hypertension (ISH) (systolic BP [SBP] ≥140 mmHg and diastolic BP <90 mmHg), characterized by increased vascular stiffness, is the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahfoud, Felix, Bakris, George, Bhatt, Deepak L., Esler, Murray, Ewen, Sebastian, Fahy, Martin, Kandzari, David, Kario, Kazuomi, Mancia, Giuseppe, Weber, Michael, Böhm, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381589/ https://www.ncbi.nlm.nih.gov/pubmed/28158510 http://dx.doi.org/10.1093/eurheartj/ehw325

Ejemplares similares

Renal denervation after the symplicity HTN-3 trial
por: Warchoł-Celińska, Ewa, et al.
Publicado: (2014)

Renal Denervation after Symplicity HTN-3: An Update
por: Persu, Alexandre, et al.
Publicado: (2014)

SYMPLICITY HTN 3: The death knell for renal denervation in hypertension?
por: Patel, Hitesh C, et al.
Publicado: (2014)

Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry
por: Mahfoud, Felix, et al.
Publicado: (2019)

Clinical event reductions in high-risk patients after renal denervation projected from the global SYMPLICITY registry
por: Schmieder, Roland E, et al.
Publicado: (2022)

Outcomes Following Radiofrequency Renal Denervation According to Antihypertensive Medications: Subgroup Analysis of the Global SYMPLICITY Registry DEFINE
por: Mahfoud, Felix, et al.
Publicado: (2023)

Renal sympathetic denervation after Symplicity HTN-3 and therapeutic drug monitoring in severe hypertension
por: Fadl Elmula, Fadl Elmula M., et al.
Publicado: (2015)

Retrospective morphometric study of the suitability of renal arteries for renal denervation according to the Symplicity HTN2 trial criteria
por: Schönherr, Elisabeth, et al.
Publicado: (2016)

SYMPLICITY HTN-3 results to be announced: a mystery or a story foretold?
por: Staessen, Jan A, et al.
Publicado: (2014)

Renal ablation for treatment of hypertension without Symplicity catheter: The first human experience
por: Honarvar, Mehrdad, et al.
Publicado: (2013)

Rationale and design of two randomized sham-controlled trials of catheter-based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN-OFF MED Pivotal) and presence (SPYRAL HTN-ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design
por: Böhm, Michael, et al.
Publicado: (2020)

Correction to: Rationale and design of two randomized sham‑controlled of catheter‑based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN‑OFF MED Pivotal) and presence (SPYRAL HTN‑ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design
por: Böhm, Michael, et al.
Publicado: (2020)

Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial
por: Kario, Kazuomi, et al.
Publicado: (2022)

Twenty-Four-Hour Pulsatile Hemodynamics Predict Brachial Blood Pressure Response to Renal Denervation in the SPYRAL HTN-OFF MED Trial
por: Weber, Thomas, et al.
Publicado: (2022)

Hypertension urgencies in the SPYRAL HTN-OFF MED Pivotal trial
por: Weber, Michael A., et al.
Publicado: (2022)

A re-examination of the SPYRAL HTN-OFF MED Pivotal trial with respect to the underlying model assumptions
por: Böhm, Michael, et al.
Publicado: (2021)

Procedural and anatomical predictors of renal denervation efficacy using two radiofrequency renal denervation catheters in a porcine model
por: Wolf, Milan, et al.
Publicado: (2018)

Changes in 24-Hour Patterns of Blood Pressure in Hypertension Following Renal Denervation Therapy
por: Kario, Kazuomi, et al.
Publicado: (2019)

Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials
por: Kirtane, Ajay J., et al.
Publicado: (2023)

Predictors of blood pressure response to ultrasound renal denervation in the RADIANCE-HTN SOLO study
por: Saxena, Manish, et al.
Publicado: (2021)

Renal Denervation for Chronic Heart Failure: Background and Pathophysiological Rationale
por: Böhm, Michael, et al.
Publicado: (2017)

Lessons Learned from RADIOSOUND-HTN: Different Technologies and Techniques for Catheter-based Renal Denervation and Their Effect on Blood Pressure
por: Lurz, Philipp, et al.
Publicado: (2019)

Treating resistant hypertension: role of renal denervation
por: Urban, Daniel, et al.
Publicado: (2013)

Effect of the Nonsteroidal Mineralocorticoid Receptor Blocker, Esaxerenone, on Nocturnal Hypertension: A Post Hoc Analysis of the ESAX-HTN Study
por: Kario, Kazuomi, et al.
Publicado: (2020)

Long-Term Results up to 12 Months After Catheter-Based Alcohol-Mediated Renal Denervation for Treatment of Resistant Hypertension
por: Mahfoud, Felix, et al.
Publicado: (2021)

A drug-induced hypotensive challenge to verify catheter-based radiofrequency renal denervation in an obese hypertensive swine model
por: Lauder, Lucas, et al.
Publicado: (2020)

Vascular lesions induced by renal nerve ablation as assessed by optical coherence tomography: pre- and post-procedural comparison with the Simplicity® catheter system and the EnligHTN™ multi-electrode renal denervation catheter
por: Templin, Christian, et al.
Publicado: (2013)

Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation: Prespecified Analysis at 6 Months of the RADIANCE-HTN TRIO Randomized Clinical Trial
por: Azizi, Michel, et al.
Publicado: (2022)

Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial
por: Khanal, Suraj, et al.
Publicado: (2014)

Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial
por: Worthley, Stephen G., et al.
Publicado: (2013)

Systolic hypertension: an increasing clinical challenge in Asia
por: Park, Jeong Bae, et al.
Publicado: (2015)

Effect of Visit‐to‐Visit Variation of Heart Rate and Systolic Blood Pressure on Outcomes in Chronic Systolic Heart Failure: Results From the Systolic Heart Failure Treatment With the I (f) Inhibitor Ivabradine Trial (SHIFT) Trial
por: Böhm, Michael, et al.
Publicado: (2016)

Is isolated systolic hypertension an indication for renal denervation?
por: Wang, Yutang
Publicado: (2014)

Renal Denervation in Asia: Consensus Statement of the Asia Renal Denervation Consortium
por: Kario, Kazuomi, et al.
Publicado: (2020)

Renal sympathetic denervation restores aortic distensibility in patients with resistant hypertension: data from a multi-center trial
por: Stoiber, Lukas, et al.
Publicado: (2018)

Effect of antihypertensive treatment on 24-h blood pressure variability: pooled individual data analysis of ambulatory blood pressure monitoring studies based on olmesartan mono or combination treatment
por: Omboni, Stefano, et al.
Publicado: (2018)

A Japan nationwide web-based survey of patient preference for renal denervation for hypertension treatment
por: Kario, Kazuomi, et al.
Publicado: (2021)

Renal denervation reduces left ventricular mass in patients with resistant hypertension - results from a multicenter CMR-study
por: Mahfoud, Felix, et al.
Publicado: (2013)

Histological evidence supporting the durability of successful radiofrequency renal denervation in a normotensive porcine model
por: Sharp, Andrew S.P., et al.
Publicado: (2022)

Epidemiologic features and management of hypertension in Tunisia, the results from the Hypertension National Registry (NaTuRe HTN)
por: Abid, Leila, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cv453iqih7pqkjo0grqofcaf1c